Public Company List
| Ticker | Company | Lead Asset | Indication | Stage | Next Catalyst |
|---|---|---|---|---|---|
| CVM | Cel-Sci Corp | CEL-SCI Corporation | Multikine Phase 3 Data Published in Peer-Reviewed Scientific Journal Pathology and Oncology Research | Phase 3 | 2026-08 |
| GRI | GRI Bio Inc | Quadrivalent influenza modRNA vaccine | Influenza, Human | Phase 3 | 2037-11 |
| DYAI | Dyadic International Inc, DE | Reliable supply, consistent quality | n/a | n/a | n/a |
| QNCX | Quince Therapeutics Inc | Dexamethasone sodium phosphate | Ataxia Telangiectasia | Phase 3 | n/a |